SPYRE THERAPEUTICS, INC. (SYRE) Capital expenditures 2016–2024
SPYRE THERAPEUTICS, INC. (SYRE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2024 · since FY2016: $212,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $38,000 | -93.4% |
| FY2021 | $573,000 | -86.6% |
| FY2020 | $4.3M | +186.9% |
| FY2019 | $1.5M | +253.6% |
| FY2018 | $422,000 | -31.8% |
| FY2017 | $619,000 | +192.0% |
| FY2016 | $212,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice